Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,847,571 papers from all fields of science
Search
Sign In
Create Free Account
RAEB-2
Known as:
RAEB-II
A myelodysplastic syndrome defined by 10-19% blasts in the bone marrow or 5-19% blasts in the blood and <10% blasts in the bone marrow…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Agranulocytosis
Anemia
Bone Marrow
Bone marrow stem cell
Expand
Broader (2)
MYELODYSPLASTIC SYNDROME
Refractory anaemia with excess blasts
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Leczenie upustami krwi przeładowania żelazem u pacjenta z zespołem mielodysplastycznym w trakcie skutecznego leczenia azacytydyną
Hanna Ciepłuch
Hematologia
2019
Corpus ID: 208376896
We present the case of 75 year-old-man who was treated with azacitidine because of myelodysplastic syndrome RAEB-2 (refractory…
Expand
2016
2016
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
S. Gritsaev
,
I. Kostroma
,
+7 authors
K. Abdulkadyrov
2016
Corpus ID: 76831670
Aim. The aim of this paper is to evaluate the effectiveness of low dose cytarabine (Ara-C) combined with cladribine for the…
Expand
2015
2015
Рефрактерные анемии и цитопении как диагностические критерии при миелодиспластических синдромах
А.К. Косанова
,
Э.З. Габбасова
,
+7 authors
Л.М. Туреханова
2015
Corpus ID: 78414669
Analysis of the results of the present study showed that the ratio of violations of the peripheral blood cells in patients with…
Expand
2013
2013
Refractory Anemia with Excess Blasts-2 Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or A Phase I Trial of Vorinostat and Alvocidib in Patients with
B. Holkova
,
J. Supko
,
M. Ames
2013
Corpus ID: 74205758
Abstract Purpose:ThisphaseIstudywasconductedtoidentifythemaximum-tolerateddose(MTD)ofalvocidibwhen combined with vorinostat in…
Expand
2012
2012
[Fatal disseminated toxoplasmosis after unrelated bone marrow transplantation for myelodysplastic syndrome].
Jun Kato
,
T. Mori
,
+4 authors
S. Okamoto
[Rinsho ketsueki] The Japanese journal of…
2012
Corpus ID: 20709669
A 44-year-old man with myelodysplastic syndrome (RAEB-2) underwent allogeneic bone marrow transplantation from an unrelated donor…
Expand
Review
2011
Review
2011
Refractory anemia with excess blasts (RAEB)
A. Cuneo
,
G. Castoldi
2011
Corpus ID: 72570680
Review on Refractory anemia with excess blasts (RAEB), with data on clinics, and the genes involved.
2011
2011
t(3;7)(q26;q21) as a secondary abnormality in MDS RAEB-2
L. Reindl
,
C. Haferlach
2011
Corpus ID: 85367778
2010
2010
Cutaneous Leukocytoclastic Vasculitis and Myelodysplastic Syndrome With Little or No Evidence of Associated Autoimmune Disorders
R. Chhabra
,
Stuart Hinton
2010
Corpus ID: 265865943
Cutaneous leukocytoclastic vasculitis (CLV) is a necrotizing inflammatory disease of the small vessels in the dermis…
Expand
2008
2008
顆粒球輸血の併用により同種造血幹細胞移植を施行し得た肺炎合併MDS-RAEB-2
玲菜 守田
,
聡 橋野
,
+6 authors
正博 浅香
2008
Corpus ID: 209119367
We report that granulocyte transfusion (GTX) was effective for prolonged pneumonia at allogeneic bone marrow transplantation. A…
Expand
2007
2007
Good Response to Decitabine in an Elderly Patient with MDS (Refractory Anemia with Excess Blasts RAEB-2) after Failure of Azacitidine.
Ashraf R. Aziz
2007
Corpus ID: 78764939
Decitabine, A pyrimidine nucleoside analog of cytidine, 5-aza-2′-deoxycytidine strongly inhibits DNA methylation, is capable of…
Expand